Endocannabinoids effect on oxidative status of human platelets

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Reactive oxygen species (ROS) regulate platelet activation.
• Endocannabinoids act as platelet agonists.
• The impact of endocannabinoids on platelet oxidative status requires investigation.

Purpose of the Study:

• To investigate the effect of 2-arachidonoylglycerol (2AG) and anandamide (AEA) on human platelet oxidative status.
• To elucidate the role of cannabinoid receptors (CB1 and CB2) in mediating these effects.
• To explore the impact of endocannabinoids on platelet aerobic metabolism.

Main Methods:

• Measurement of ROS production, superoxide anion formation, and lipid peroxidation in human platelets.
• Utilized specific inhibitors for cannabinoid receptor 1 (SR141716) and cannabinoid receptor 2 (SR144528).
• Assessed oxygen consumption, ATP synthesis, and mitochondrial respiratory complex activities.

Main Results:

• 2AG and AEA dose- and time-dependently stimulated ROS production, superoxide anion formation, and lipid peroxidation, primarily through CB1 receptor activation.
• Endocannabinoids reduced oxygen consumption and ATP synthesis, inhibited respiratory complexes II, III, and IV, and increased complex I activity.
• The syk/PI3K/AKT/mTor pathway was involved, while nicotinamide adenine dinucleotide phosphate oxidase played a minor role.

Conclusions:

• Endocannabinoids induce oxidative stress and alter aerobic metabolism in human platelets, predominantly via CB1 receptor activation.
• Oxidative stress in platelets, generated in the respiratory chain, may contribute to thrombotic events and cardiovascular diseases.